Child-Pugh Score C Mortality and Management
Patients with Child-Pugh Class C cirrhosis have a 1-year survival of approximately 45-50% and should receive only supportive palliative care, with liver transplantation being the sole potentially curative option for highly selected candidates who meet strict transplant criteria. 1, 2, 3
Mortality Data
- 1-year survival for Child-Pugh C patients is approximately 45-50% 1
- 7-year survival rates are dramatically stratified: 90% for Child-Pugh A, 68% for Child-Pugh B, and only 25% for Child-Pugh C 4
- Median survival without transplantation is measured in months rather than years, often less than 3 months in end-stage patients 5, 3
- In patients with acute variceal bleeding, Child-Pugh C mortality reaches 35.6% within 6 weeks, compared to only 11.7% for Child-Pugh B patients 6
Contraindicated Treatments
The following treatments must be avoided in Child-Pugh C patients due to prohibitively high mortality risk:
- Interferon-based antiviral regimens are absolutely contraindicated due to high risk of life-threatening complications, even when viral hepatitis is the underlying etiology 3
- Surgical resection for hepatocellular carcinoma is not recommended as operative mortality is excessive 7, 3
- Systemic chemotherapy is contraindicated due to severely compromised liver function 2, 3
- Most active oncologic treatments outlined in guidelines are inappropriate for this population 2, 7
Management Algorithm
Step 1: Assess Transplant Candidacy
- Evaluate if patient meets transplant criteria: age <65 years, meets Milan criteria if HCC present (single tumor ≤5 cm or up to 3 tumors none >3 cm) 7, 3
- Calculate MELD score for transplant listing priority 2, 7
- Selected Child-Pugh C patients with HCC within Milan criteria may be considered for transplantation 7
Step 2: If Not a Transplant Candidate
- Transition to palliative care focus 2, 3
- Manage complications as they arise with supportive measures only 2, 3
Management of Specific Complications
Hepatic Encephalopathy:
- Lactulose titrated to 2-3 soft bowel movements daily 3
Ascites:
- Dietary sodium restriction to <2 grams/day 3
- Norfloxacin prophylaxis to prevent spontaneous bacterial peritonitis in patients with ascites 3
Acute Variceal Hemorrhage:
- Endoscopic management with band ligation or sclerotherapy 3
- Note: Child-Pugh C patients with variceal bleeding have 3-fold higher mortality (35.6%) compared to Child-Pugh B (11.7%) 6
Common Pitfalls to Avoid
- Do not attempt antiviral therapy even if viral hepatitis is the underlying cause - this remains contraindicated regardless of etiology 3
- Do not pursue surgical resection for HCC even for small lesions - operative mortality is excessive in this population 7, 3
- Do not use MELD score alone for prognosis - it may fluctuate highly and overestimate disease stage due to biliary obstruction affecting bilirubin 4
- Do not assume all Child-Pugh C patients are identical - temporary events like renal failure, spontaneous bacterial peritonitis, hyponatremia, or recurrent encephalopathy may indicate end-stage disease requiring immediate transplant evaluation or hospice 8
Prognostic Context
The Child-Pugh classification uses 5 variables (albumin, ascites, bilirubin, prothrombin time/INR, encephalopathy) with scores of 10-15 points defining Class C 1, 9. This scoring system has been validated across multiple liver diseases including primary sclerosing cholangitis, hepatocellular carcinoma, and variceal bleeding, consistently demonstrating its prognostic value 4, 6, 10.